Boeing (BA) shares rallied on Tuesday despite reporting a wider-than-expected Q2 loss of 76 cents per share, driven primarily by a $280 million one-time charge related to the VC-25B presidential jet program. Investors remain optimistic because management maintained its full-year free cash flow guidance of up to $3 billion and signaled a potential reinstatement of long-term guidance targeting approximately $10 billion in free cash flow. The primary catalyst for Boeing's stock performance is the anticipated regulatory clearance for its commercial aircraft portfolio. CEO Kelly Ortberg indicated that flight testing for the 737 MAX 7 and MAX 10 variants is complete, with FAA certification expected shortly for the -7 model and later this year for the -10. Additionally, certification work on the 777X widebody continues alongside strong international demand, positioning deliveries from the massive backlog to accelerate starting in 2027. A significant long-term growth pillar involves a recent high-level trip to Beijing with President Trump, resulting in a headline commitment for 200 aircraft from Chinese carriers. While this represents Boeing's first major sale to China in nearly a decade, CEO Ortberg clarified that the initial commitment is still in the allocation and contract negotiation phase rather than firm orders. The company expects these binding agreements to close in the coming months, which would formally lock in orders and expand the backlog. Boeing's Defense, Space & Security unit continues to navigate legacy fixed-price contracts that historically weigh on profits, though revenue in this segment rose 13% in Q2. Key operational milestones include full-rate production for the T-7 trainer jet and low-rate initial production authorization for the MQ-25 tanker. Analysts currently rate the stock as 'Overweight' with a mean price target of roughly $281, reflecting confidence in the company's path to stabilizing cash flow once regulatory hurdles are cleared.